[HTML][HTML] Proteomics and extracellular vesicles as novel biomarker sources in peritoneal dialysis in children
C Trincianti, V Meleca, E La Porta, M Bruschi… - International Journal of …, 2022 - mdpi.com
Peritoneal dialysis (PD) represents the dialysis modality of choice for pediatric patients with
end-stage kidney disease. Indeed, compared with hemodialysis (HD), it offers many …
end-stage kidney disease. Indeed, compared with hemodialysis (HD), it offers many …
[HTML][HTML] Proteomics and Extracellular Vesicles as Novel Biomarker Sources in Peritoneal Dialysis in Children
C Trincianti, V Meleca, E La Porta… - … Journal of Molecular …, 2022 - ncbi.nlm.nih.gov
Peritoneal dialysis (PD) represents the dialysis modality of choice for pediatric patients with
end-stage kidney disease. Indeed, compared with hemodialysis (HD), it offers many …
end-stage kidney disease. Indeed, compared with hemodialysis (HD), it offers many …
Proteomics and Extracellular Vesicles as Novel Biomarker Sources in Peritoneal Dialysis in Children.
C Trincianti, V Meleca, E La Porta… - … Journal of Molecular …, 2022 - europepmc.org
Peritoneal dialysis (PD) represents the dialysis modality of choice for pediatric patients with
end-stage kidney disease. Indeed, compared with hemodialysis (HD), it offers many …
end-stage kidney disease. Indeed, compared with hemodialysis (HD), it offers many …
Proteomics and Extracellular Vesicles as Novel Biomarker Sources in Peritoneal Dialysis in Children
C Trincianti, V Meleca, E La Porta… - International …, 2022 - pubmed.ncbi.nlm.nih.gov
Peritoneal dialysis (PD) represents the dialysis modality of choice for pediatric patients with
end-stage kidney disease. Indeed, compared with hemodialysis (HD), it offers many …
end-stage kidney disease. Indeed, compared with hemodialysis (HD), it offers many …
Proteomics and Extracellular Vesicles as Novel Biomarker Sources in Peritoneal Dialysis in Children
C Trincianti, V Meleca, E La Porta, M Bruschi… - 2022 - agris.fao.org
Peritoneal dialysis (PD) represents the dialysis modality of choice for pediatric patients with
end-stage kidney disease. Indeed, compared with hemodialysis (HD), it offers many …
end-stage kidney disease. Indeed, compared with hemodialysis (HD), it offers many …
Proteomics and Extracellular Vesicles as Novel Biomarker Sources in Peritoneal Dialysis in Children
C Trincianti, V Meleca, E La Porta… - International …, 2022 - search.proquest.com
Peritoneal dialysis (PD) represents the dialysis modality of choice for pediatric patients with
end-stage kidney disease. Indeed, compared with hemodialysis (HD), it offers many …
end-stage kidney disease. Indeed, compared with hemodialysis (HD), it offers many …
Proteomics and Extracellular Vesicles as Novel Biomarker Sources in Peritoneal Dialysis in Children.
C Trincianti, V Meleca, E La Porta… - International …, 2022 - search.ebscohost.com
Peritoneal dialysis (PD) represents the dialysis modality of choice for pediatric patients with
end-stage kidney disease. Indeed, compared with hemodialysis (HD), it offers many …
end-stage kidney disease. Indeed, compared with hemodialysis (HD), it offers many …